ASSOCIATION BETWEEN HLA CLASS-II ANTIGENS AND PRIMARY ANTIPHOSPHOLIPID SYNDROME FROM THE SOUTH OF SPAIN

被引:31
作者
CAMPS, MT
CUADRADO, MJ
OCON, P
ALONSO, A
GUTIERREZ, A
GUIL, M
GRANA, MI
DERAMON, E
机构
[1] HOSP REG SERV ANDALUZ S ALUD,SERV MED INTERNA,UNIDAD ENFERMEDADES AUTOIMMUNES SISTEM,MALAGA,SPAIN
[2] HOSP UNIV REINA SOFIA,SECC REUMATOL,CORDOBA,SPAIN
[3] HOSP REG SERV ANDALUZ DE SALUD,SERV LAB,SECC BIOQUIM,MALAGA,SPAIN
关键词
HLA CLASS II ANTIGENS; PAPS; S-SPAIN;
D O I
10.1177/096120339500400111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have suggested an association between primary antiphospholipid syndrome (PAPS), antiphospholipid antibodies and some major histocompatibility complex (MHC) antigens. We have studied the relationship between MHC class II antigens and PAPS in 19 patients from the south of Spain. Univariant analysis showed an association between PAPS and HLA-DQ7 (47% vs 25%1 P = 0.03), DR4 (32% vs 16%; P = 0.08) and DQ3 (63% vs 39%; P = 0.04). However, multivariant analysis confirmed the association with DQ7 (RR = 2.5; CI 80%: 1.3-4.7) and DR4 (RR = 2.2; CI 80%: 1.1-4.4) but not with DQ3. When we introduced DRw53 into this analysis, we noticed a DR4 confounding effect, with DQ7 (RR = 3.1; CI 80%: 1.7-5.8) and Drw53 (RR = 2.3; CI 80% : 1.2-4.4) remaining as the most important HLA antigens related to PAPS. In conclusion, in PAPS patients from the South of Spain, HLA-DQ7 antigen showed the highest relative risk for PAPS, followed by DRw53.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 32 条
[1]   IMMUNOLOGY OF DNA .3. CRITHIDIA-LUCILIAE, A SIMPLE SUBSTRATE FOR DETERMINATION OF ANTI-DSDNA WITH IMMUNOFLUORESCENCE TECHNIQUE [J].
AARDEN, LA ;
DEGROOT, ER ;
FELTKAMP, TEW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 254 :505-515
[2]   MOLECULAR ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLELES ASSOCIATED WITH THE LUPUS ANTICOAGULANT [J].
ARNETT, FC ;
OLSEN, ML ;
ANDERSON, KL ;
REVEILLE, JD .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1490-1495
[3]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[4]  
ASHERSON RA, 1988, J RHEUMATOL, V15, P1742
[5]  
ASHERSON RA, 1992, ARTHRITIS RHEUM, V35, P1124
[6]   NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1991 [J].
BODMER, JG ;
MARSH, SGE ;
ALBERT, ED ;
BODMER, WF ;
DUPONT, B ;
ERLICH, HA ;
MACH, B ;
MAYR, WR ;
PARHAM, P ;
SASAZUKI, T ;
SCHREUDER, GMT ;
STROMINGER, JL ;
SVEJGAARD, A ;
TERASAKI, PI .
TISSUE ANTIGENS, 1992, 39 (04) :161-173
[7]  
DAGENAIS P, 1992, J RHEUMATOL, V19, P1393
[8]  
EXNER T, 1978, BRIT J HAEMATOL, V54, P709
[9]   MAJOR HISTOCOMPATIBILITY COMPLEX GENES AND SUSCEPTIBILITY TO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FRONEK, Z ;
TIMMERMAN, LA ;
ALPER, CA ;
HAHN, BH ;
KALUNIAN, K ;
PETERLIN, BM ;
MCDEVITT, HO .
ARTHRITIS AND RHEUMATISM, 1990, 33 (10) :1542-1553
[10]  
GALLEAZZI M, 1992, LUPUS S1, V1, P33